Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
NexGel Inc Warrant (NXGLW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/26/2025: NXGLW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -91.96% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/26/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.52 | 52 Weeks Range 0.22 - 0.95 | Updated Date 05/15/2025 |
52 Weeks Range 0.22 - 0.95 | Updated Date 05/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.39 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -30.7% | Operating Margin (TTM) -27.69% |
Management Effectiveness
Return on Assets (TTM) -20.77% | Return on Equity (TTM) -60.08% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 6447417 |
Shares Outstanding - | Shares Floating 6447417 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
NexGel Inc Warrant
Company Overview
History and Background
NexGel, Inc. develops, manufactures, and markets high water content, cross-linked polymer hydrogels. The warrants give the holder the right to purchase shares of NexGel stock at a specified price.
Core Business Areas
- Hydrogels: Development, manufacturing, and marketing of hydrogels for various applications.
Leadership and Structure
Information on the specific leadership team and organizational structure of NexGel is limited in publicly available resources. Further research might be required.
Top Products and Market Share
Key Offerings
- Hydrogels: NexGel develops high water content hydrogels, which are used in wound care, cosmetics, and drug delivery. Market share data is not readily available. Competitors vary by specific application area but include companies specializing in advanced wound care, such as Smith & Nephew (SNN), and companies producing cosmetic ingredients, such as Croda International (CRDA.L).
Market Dynamics
Industry Overview
The hydrogel market is growing, driven by increasing demand in healthcare, cosmetics, and other industries. Factors like aging populations, rising healthcare expenditure, and technological advancements contribute to this growth.
Positioning
NexGel aims to be a provider of high-quality, innovative hydrogel solutions. Its competitive advantage lies in its unique hydrogel formulations and manufacturing processes.
Total Addressable Market (TAM)
The global hydrogel market is expected to reach billions of dollars. NexGel's position within the TAM depends on its ability to penetrate specific application areas and secure market share. No data on TAM.
Upturn SWOT Analysis
Strengths
- Proprietary hydrogel technology
- Potential for applications in diverse markets
- Focus on high water content hydrogels
Weaknesses
- Limited market presence
- Reliance on a few key products
- Potentially limited access to capital
Opportunities
- Expansion into new application areas
- Partnerships with larger companies
- Increased demand for advanced wound care products
Threats
- Competition from established players
- Technological advancements by competitors
- Regulatory changes
Competitors and Market Share
Key Competitors
- Smith & Nephew (SNN)
- Convatec Group PLC (CTEC.L)
Competitive Landscape
NexGel faces competition from larger, more established players. Its success depends on its ability to differentiate its hydrogel solutions and secure market share in specific application areas.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is not readily available without access to NexGel's financial reports.
Future Projections: Future projections would depend on analyst estimates of NexGel's revenue growth, profitability, and market penetration.
Recent Initiatives: Recent initiatives would need to be gathered from NexGel's press releases, investor presentations, and other public disclosures.
Summary
NexGel is a small company focused on developing hydrogel technologies. Its success hinges on innovation, market penetration, and securing funding. It faces intense competition from larger companies and requires a strong strategic plan to thrive in the competitive landscape. Information on its financial health is difficult to ascertain.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Market Research Reports
- Financial News Articles
Disclaimers:
The information provided is based on publicly available data and is for informational purposes only. It should not be construed as financial advice. Market share data is estimated and may not be precise. Investing in warrants involves significant risk.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NexGel Inc Warrant
Exchange NASDAQ | Headquaters Langhorne, PA, United States | ||
IPO Launch date 2021-12-22 | CEO, President & Director Mr. Adam R. Levy | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 19 | Website https://nexgel.com |
Full time employees 19 | Website https://nexgel.com | ||
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.